GILD Gilead Sciences, Inc.
$158.69▲ +1.70%
Healthcare
Other
Pre-market
$158.86▲ +0.11%
Oct 27, 7:35 AM ET
Volume 6.04M
Avg Volume (10D) 6.45M
Key Metrics & Fundamentals
Market Cap
$196.77B
P/E Ratio
18.4
Div Yield
2.07%
52W Range
114.02 - 160.51
% vs 50 MA
6.33%
% vs 200 MA
14.12%
RSI-14
61.9
MACD Histogram
+0.5600
Beta (1Y vs SPY)
0.30
Free Cash Flow
$3.43B
Gross Rev
$7.80B
Gross Profit
$6.22B
EBITDA
$3.28B
COGS
$1.58B
Operating Exp
$3.69B
Operating Income
$2.54B
EBIT
$2.54B
Pretax Income
-$10.25B
Net Income
-$10.50B
EPS (Diluted)
-8.45
Price & Volume History
Loading chart…
Recent News
Canadians Living with Primary Biliary Cholangitis (PBC) One Step Closer to New Treatment Option as Gilead Reaches Milestone National Agreement for LYVDELZI® (seladelpar)
CNW Group · Oct 27, 2026 8:00 AM ET
Avantis U.S. Large Cap Value (AVLV) Sells $42.9 Million More MetLife on Friday
GuruFocus.com · Oct 27, 2026 7:04 AM ET
ETFs Are Net Sellers of Gilead Sciences (GILD) on Oct. 23
GuruFocus.com · Oct 27, 2026 7:03 AM ET
Fed Meeting, More Tech Earnings: What to Watch This Week
The Wall Street Journal · Oct 27, 2026 4:02 AM ET
What Would A Biktarvy Slowdown Do To Gilead Stock?
Trefis · Oct 26, 2026 5:21 PM ET
BHC Q3 Earnings Preview: Here's What You Should Know
Zacks · Oct 26, 2026 1:33 PM ET
Another autoimmune CAR-T death; Treasury zeroes in on China deals
BioPharma Dive · Oct 26, 2026 9:59 AM ET
TG Therapeutics (TGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Oct 26, 2026 9:00 AM ET
Biogen Q3 Preview: Will Growth Products Drive an Earnings Beat?
Zacks · Oct 26, 2026 8:38 AM ET
Ahead of Gilead (GILD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks · Oct 26, 2026 8:15 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GILD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.